Xiao Ni

3.0k citations
43 papers · 2.3k indexed · 1 hit paper · h-index 20

Impact in

Papers in

    • Cutaneous lymphoproliferative disorders research 29
    • T-cell and Retrovirus Studies 18
    • Immunotherapy and Immune Responses 4

Xiao Ni

37 papers receiving 2.3k citations

Hit Papers

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) 2006 · 875 citations
8752006202620122019250500750

Peers

Xiao Ni
Comparison fields: 5 of 89
  • Dermatology 890
  • Pathology and Forensic Medicine 709
  • Immunology 711
  • Oncology 580
  • Molecular Biology 1.1k
Replace Chalid Assaf with:
Chalid Assaf Germany
Katherine C. Pierson United States
Zhilan Hu United States
Daniel Wu United States
Toshihiko Shirai Japan
Makiko Kawaguchi Japan
Mariko Kashiwagi Japan
Brigitte Lankat–Buttgereit Germany
Jean S. Beebe United States
F. Caux France
Xiao Ni relative to Chalid Assaf Germany Chalid Assaf's profile →
Citations per field
00.5×1.7×
Chalid Assaf · 1×
Citations per year

Countries citing papers authored by Xiao Ni

Since Specialization
Citations

This map shows the geographic impact of Xiao Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Ni more than expected).

Fields of papers citing papers by Xiao Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Ni. The network helps show where Xiao Ni may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiao Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiao Ni Line = papers co-authored together Xiao Ni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20240
4 20242
5 20238
6 20235
7 20211
8 20210
9 202116
10 20204
11 201823
12 201621
13 201530
14 201211
15 201224
16 200917
17 200615
18 200543
19 200442
20 200332

About Xiao Ni

Xiao Ni is a scholar working on Dermatology, Immunology, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 43 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (29 papers), T-cell and Retrovirus Studies (18 papers), CAR-T cell therapy research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Immunotherapy and Immune Responses (4 papers), Retinoids in leukemia and cellular processes (3 papers), Fungal Infections and Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Dermatology (890 citations), Pathology and Forensic Medicine (709 citations), Immunology (711 citations), Oncology (580 citations) and Molecular Biology (1.1k citations). Xiao Ni has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Madeleine Duvic, Chunlei Zhang, Parul Hazarika, Victoria M. Richon, Cecilia Kelly, Judy H. Chiao, Justin L. Ricker, John F. Reilly, Stanley R. Frankel and Rakhshandra Talpur. Their work appears in journals such as Journal of Investigative Dermatology, Blood, Photodermatology Photoimmunology & Photomedicine, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026